Physician
Oncology
Dr. Ke Liu, MD
|
|
Give Review
is an expert in the field of Oncology. has written publications. He has 18 publications published with PubMed. The lastest paper is: 'Environmentally Relevant Concentrations of Arsenite and Monomethylarsonous Acid Inhibit IL-7/STAT5 Cytokine Signaling Pathways in Mouse CD3+CD4-CD8- Double Negative Th...' He is registered with Medicare.
Publications
- Environmentally Relevant Concentrations of Arsenite and Monomethylarsonous Acid Inhibit IL-7/STAT5 Cytokine Signaling Pathways in Mouse CD3+CD4-CD8- Double Negative Th...
- Nitric Oxide Interacts with Caveolin-1 to Facilitate Autophagy-Lysosome-Mediated Claudin-5 Degradation in Oxygen-Glucose Deprivation-Treated Endothelial Cells.
- Monomethylarsonous acid (MMA+3) Inhibits IL-7 Signaling in Mouse Pre-B Cells.
- Arsenite Interacts with Dibenzo[def,p]chrysene (DBC) at Low Levels to Suppress Bone Marrow Lymphoid Progenitors in Mice.
- Autophagy Mediates Astrocyte Death During Zinc-Potentiated Ischemia-Reperfusion Injury.
- Discrimination of novel bunyavirus infection using routine laboratory test.
- Pulsed electron paramagnetic resonance study of domain docking in neuronal nitric oxide synthase: the calmodulin and output state perspective.
- In vivo evidence of methamphetamine induced attenuation of brain tissue oxygenation as measured by EPR oximetry.
- Differential Binding of Monomethylarsonous Acid Compared to Arsenite and Arsenic Trioxide with Zinc Finger Peptides and Proteins.
- Arsenite binding-induced zinc loss from PARP-1 is equivalent to zinc deficiency in reducing PARP-1 activity, leading to inhibition of DNA repair.
- Structure-activity relationship of imidazopyridinium analogues as antagonists of neuropeptide s receptor.
- A Phenotypic Compound Screening Assay for Lysosomal Storage Diseases.
- δ-Tocopherol Reduces Lipid Accumulation in Niemann-Pick Type C1 and Wolman Cholesterol Storage Disorders.
- Rare Cancer Trial Design: Lessons from FDA Approvals.
- Differential susceptibility of human peripheral blood T cells to suppression by environmental levels of sodium arsenite and monomethylarsonous Acid.
- Extended normobaric hyperoxia therapy yields greater neuroprotection for focal transient ischemia-reperfusion in rats.
- Arsenite selectively inhibits mouse bone marrow lymphoid progenitor cell development in vivo and in vitro and suppresses humoral immunity in vivo.
Conditions Treated
- Breast Cancer
- Pancreatic Cancer
- Prostate Cancer
- Secondary Malignancies
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
- Aetna
- Blue Cross Blue Shield
- Cigna
- Commercial Insurance Company
- Coventry Health Care
- GEHA
- Kaiser Permanente
- Maryland Physicians Care
- Medicaid
- Medicare MCR
- United Healthcare
Education
-
National Institutes of Health Clinical Center -
North Shore-Long Island Jewish Health System
Hospital
-
Calvert Memorial Hospital
Drug Facts
| NPI NUMBER | 1841329174 | |
| NPPES Provider LastName | LIU | |
| NPPES Provider FirstName | KE | |
| NPPES Provider ZIPCode | 206223188 | |
| NPPES Provider State | MD | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 18.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1841329174 |
| Last Name Of The Provider | LIU |
| First Name Of The Provider | KE |
| View All |